Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease
Complete Title: Acalabrutinib for Chronic Graft-Versus-Host Disease
Trial Phase: II
Investigator: Stephanie Lee
This phase II trial studies how well acalabrutinib works in treating patients with chronic graft versus host disease. Acalabrutinib may be an effective treatment for graft-versus-host disease caused by a stem cell transplant.
Keywords:
- Graft Versus Host Disease, Chronic (cGVHD)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
Adult
II
Stephanie Lee
RG1006135
NCT04198922
Acalabrutinib for Chronic Graft-Versus-Host Disease
Graft Versus Host Disease, Chronic (cGVHD)